How Do Manufacturer Rebates Impact Drug Prices?
April 26, 2017
A statistical analysis revealed there was no correlation between price increases and rebates, according to the study. The authors found...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
Blame drug makers for high-priced drugs
April 17, 2017
When it comes to how high they price their products, drug companies want the public to ignore what they spend...
Florida legislation increases Rx costs
April 07, 2017
Florida legislators should reject this legislation that would reduce the market’s competitive forces, increase health care costs, and make patients...
PCMA Response to Anti-PBM Article in The American Prospect
March 29, 2017
A recent article (“The Hidden Monopolies that Raise Drug Prices”) gives an inaccurate and incomplete picture of pharmacy benefit managers...
New drugstore lobby mandate would increase prescription drug costs in Medicare
March 25, 2017
Legislation being pushed by various special interest drugstore lobbies would undermine Medicare Part D and destabilize the program for millions...
New PBM programs bypass insurers to offer drug discounts directly to consumers
March 22, 2017
Pharmaceutical benefit managers and tech startups are responding to underinsurance and the onslaught of high-deductible health plans by cutting out...
Health Insurers Often Foot Bill When Drug Coupons Are Used
March 16, 2017
Mark Merritt says pharmaceutical companies use coupons to boost sales and pocket profits. “Coupons primarily target drug classes where there...
STAT Q&A with PCMA President Mark Merritt: Pharmacy Benefit Managers Say ‘Consumer is King’
February 28, 2017
In the end, the consumer is king, and we’re going to negotiate the most aggressive discounts we can. That’s not...
February 28, 2017
Mark Merritt, the head of the Pharmaceutical Care Management Association, joined to share his diagnosis for high drug prices, argue...
St. Louis Post-Dispatch: Express Scripts says U.S. drugs spending rose 5.2 percent in 2015
February 17, 2017
U.S. medicine spending rose 5.2 percent in 2015, down from 10.1 percent in 2014, Express Scripts reported. The company noted...
Minneapolis Star-Tribune: Growth in cost of medicine moderated in 2016, study finds
February 17, 2017
Prime Therapeutics’ nearly 20 million clients saw overall drug spending grow by 2.5 percent last year, compared with annual increases...
Specialty Pharmacy Times: Is Misinformation Spreading about Direct and Indirect Remuneration Fees?
February 14, 2017
PCMA told Specialty Pharmacy Times that DIR fees are not harmful. “They don’t harm the health industry in any way....